🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to be part of the CIEBH consortium, with partners Gandeeva Therapeutics and global pharma companies including GSK. Our project PROGENITER will leverage Canada’s investment in biomanufacturing and life sciences to bolster pandemic preparedness. ow.ly/MbL450S4FW2

Thank you to Canada, ISED , #CIEBH, and University of British Columbia for your support as we launch PROGENITER. PROGENITER is a multidisciplinary academic-industry partnership with a goal to ensure Canadian researchers and healthcare systems can respond rapidly to pandemic threats as they emerge.

We're in great company, and we look forward to working with our colleagues at Canada's Immuno-Engineering & Biomanufacturing Hub to build Canada's arsenal of ready-to-deploy antibody treatments for the next pandemic.

Congratulations to PROGENITER team members Dr. Eric Jan and Dr. Annie Ciernia on their 2024 @UBCmedicine Distinguished Achievement Awards! med.ubc.ca/news/2024-facu…

Canada’s $140M investment in CIEBH at @UBCmedicine positions BC as a global leader in life sciences. Discover what this means for the future of healthcare: ow.ly/Zfff50TeCTh

Biotech has an important role to play in helping academic and government partners scale up their capacity for pandemic preparedness, and we're proud to partner with PROGENITER to accelerate pandemic readiness at home and around the world. ow.ly/43u750TbeCI